07:00 , Sep 3, 2007 |  BioCentury  |  Strategy

Innovation & leadership

Over the past two years, Back to School has been exploring the relationship between innovation and the economic returns from drug development and the creation of patient value. These discussions have argued that as pricing...
07:00 , Mar 26, 2007 |  BioCentury  |  Product Development

Metabolic Milestones

The increasing prevalence of metabolic diseases has become a growing concern as studies continue to draw links between them and a wide array of comorbidities. As new targets and pathways come to light, the race...
07:00 , Jul 3, 2006 |  BioCentury  |  Product Development

APTP-1B salvage job

APTP-1B salvage job...
08:00 , Jan 30, 2006 |  BioCentury  |  Emerging Company Profile

Alinea: Eclectic approach to diabetes

Because of the enormous complexity of diabetes, treating the disease means not only controlling glucose, but also treating a host of neurological and cardiovascular complications. Alinea Pharmaceuticals Inc. was spun out of the Institute for...
08:00 , Jan 30, 2006 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Alinea Pharmaceuticals Inc. Cambridge, Mass. Technology: Small molecule candidates to treat diabetes and associated complications Disease focus: Endocrine Clinical status: Phase IIa Founded: 2005 by the Institute for Diabetes Discovery LLC University collaborators: NA Corporate...
08:00 , Jan 9, 2006 |  BioCentury  |  Finance

Money & milestones

Money & milestones...
07:00 , Oct 24, 2005 |  BC Week In Review  |  Company News

Alinea management update

Alinea Pharmaceuticals Inc. , Cambridge, Mass.   Business: Endocrine, Metabolic   Hired: Robert Mashal as president and CEO, formerly a partner at Boston Millennia Partners  ...
01:48 , Oct 21, 2005 |  BC Extra  |  Company News

Alinea names Mashal CEO

Alinea (Cambridge, Mass.) hired Robert Mashal as president and CEO. Previously, Mashal was a partner at Boston Millennia Partners. Alinea's lidorestat is in Phase II testing to prevent complications from diabetes....
07:00 , Oct 17, 2005 |  BioCentury  |  Finance

Ebb & Flow

Germany's...
00:05 , Oct 13, 2005 |  BC Extra  |  Financial News

Alinea raises $45 million

Alinea (Cambridge, Mass.) raised $45 million in a series A round led by MPM. Other investors included SV Life Sciences; Burrill; and Flagship Ventures. Alinea is developing a protein tyrosine phosphatase 1B ( PTP-1B )...